Chabrier, Stéphane <br/><br/>
Angiotensin-converting-enzyme inhibitors versus steroids as first-line drug treatment in Duchenne muscular dystrophy.  [electronic resource] 

 -  Developmental medicine and child neurology  Nov 2010 
 - 1067-8 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1469-8749 
<br/><br/><label>Standard No.: </label>10.1111/j.1469-8749.2010.03742.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Child<br/>Female<br/>Humans<br/>Male<br/>Movement Disorders--etiology<br/>Muscular Dystrophy, Duchenne--complications<br/>Steroids--therapeutic use